Gail M. Farfel - 19 Sep 2022 Form 4 Insider Report for ProMIS Neurosciences Inc. (PMN)

Role
Chief Executive Officer
Signature
/s/ Gail M. Farfel, by Jason L. Langford, Attorney-in-Fact
Issuer symbol
PMN
Transactions as of
19 Sep 2022
Net transactions value
$0
Form type
4
Filing time
20 Sep 2022, 16:57:37 UTC
Previous filing
17 Jun 2022
Next filing
08 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMN Option (right to buy) Award $0 +208,334 $0.000000 208,334 19 Sep 2022 Common Shares 208,334 $7.10 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Conversion or exercise price is in Canadian dollars.
F2 The option agreement provides that the option vests 25% on the one year anniversary of grant and the balance vests ratably over 36 months.